85185-24-6

Basic information

• Product Name: 3-(N-Boc)pentanedioic acid
• Synonyms: 3-(N-Boc)pentanedioic acid;3-({[(2-Methyl-2-propanyl)oxy]carbonyl}amino)pentanedioic acid
• CAS NO: 85185-24-6
• Molecular Formula: C₁₀H₁₇NO₆
• Molecular Weight: 247.24508
• Mol File: 85185-24-6.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 429.8±35.0 °C(Predicted)
• Appearance: /
• Density: 1.264±0.06 g/cm3(Predicted)
• PKA: 4.00±0.10(Predicted)
• CAS DataBase Reference: 3-(N-Boc)pentanedioic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 3-(N-Boc)pentanedioic acid(85185-24-6)
• EPA Substance Registry System: 3-(N-Boc)pentanedioic acid(85185-24-6)

Safety Data

• Hazardous Substances Data: 85185-24-6(Hazardous Substances Data)

Upstream product

• 1948-48-7 3-aminopentanedioic acid 
• 24424-99-5 di-tert-butyl dicarbonate 
• 628-48-8 glutaconic acid 
• 120341-34-6 (2,6-Dioxo-tetrahydro-pyran-4-yl)-carbamic acid tert-butyl ester 

Downstream Products

• 98577-76-5 N,N'-bis<3-<(benzyloxycarbonyl)amino>propyl>-3-pentanediamide 

Relevant articles and documents

IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF

This invention includes ionizable compounds, and compositions and methods of use thereof. The ionizable compounds can be used for making nanoparticle compositions for use in biopharmaceuticals and therapeutics. More particularly, this invention relates to compounds, compositions and methods for providing nanoparticles to encapsulate active agents, such as nucleic acid agents, and to deliver and distribute the active agents to cells, tissues, organs, and subjects.

2-CYANOPYRROLES AND THEIR ANALOGUES AS DDP-IV INHIBITORS

The present invention relates to therapeutically active and selective inhibitors of the enzyme DPP-IV having the formula I: (I) The invention furthermore relates to pharmaceutical compositions comprising the compounds and the use of such compounds for the manufacture of medicaments for treating diseases that are associated with proteins which are subject to inactivation by DPP-IV, such as type 2 diabetes and obesity.

Potential antitumor agents. 45. Synthesis, DNA-binding interaction, and biological activity of triacridine derivatives

A series of amide-linked triacridines of varying interchromophore separation were synthesized as potential DNA trisintercalating agents. The correseponding diamide diacridines (lacking the central chromophore) were also prepared, and the DNA-binding and b